Literature DB >> 3129870

Immunofluorescence characterization of light chains in human nephropathies.

C Orfila1, J Rakotoarivony, Y Manuel, J M Suc.   

Abstract

Renal tissue from 185 patients with various nephropathies were studied by immunofluorescence, in order to look for the frequency and potential predominance of kappa or lambda light chain glomerular deposits. Four normal renal biopsies were used as controls. An overall study shows that light chains were present in glomeruli in 136 out of 185 cases; kappa light chain deposits were more frequent than lambda light chain deposits (73.5% and 64.3% respectively). An analytical study shows that this was not observed in all nephropathies studied. In mesangial IgA nephropathy, lambda light chain deposits were seen in 81% of cases (29 out of 37) and kappa light chain deposits were observed in 78% (30 out of 37 cases). In lupus nephritis, lambda light chain deposits were present in 13 out of 14 cases (92.8%) whereas kappa light chain deposits were demonstrated in 12 cases (85.7%). In other nephropathies such as membranous, endocapillary proliferative and amyloid nephritis, kappa was the predominant light chain observed in glomeruli or was present in the same number of cases as lambda light chain (mesangiocapillary glomerulonephritis). These findings show that in certain nephritides, for example IgA nephropathy and lupus nephritis, IgA and IgG deposits are mainly composed of lambda light chain in contrast with the normal kappa: lambda ratio in human serum of 2:1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129870     DOI: 10.1007/bf00844295

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  10 in total

1.  The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy.

Authors:  K N Lai; K W Chan; F Mac-Moune; C P Ho; K W Yan; C W Lam; J Vallance-Owen
Journal:  Am J Clin Pathol       Date:  1986-05       Impact factor: 2.493

Review 2.  The role of the kidney in the metabolism of plasma proteins.

Authors:  W Strober; T A Waldmann
Journal:  Nephron       Date:  1974       Impact factor: 2.847

3.  Immunofluorescent localization of Tamm-Horsfall mucoprotein in human kidney.

Authors:  J K McKenzie; E G McQueen
Journal:  J Clin Pathol       Date:  1969-05       Impact factor: 3.411

Review 4.  Manifestations of systemic light chain deposition.

Authors:  R E Randall; W C Williamson; F Mullinax; M Y Tung; W J Still
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

5.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1981.

Authors: 
Journal:  N Engl J Med       Date:  1981-01-01       Impact factor: 91.245

6.  Kappa light chain glomerulosclerosis in multiple myeloma.

Authors:  A E Seymour; A J Thompson; P S Smith; A J Woodroffe; A R Clarkson
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

7.  Frequency distribution of alpha, gamma, kappa and lambda polypeptide chains in human lymphoid tissues.

Authors:  G M Bernier; J J Cebra
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

8.  The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.

Authors:  T A Waldmann; W Strober; R P Mogielnicki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

9.  Light chain distribution in immune deposits on glomeruli of kidneys in human renal disease.

Authors:  R C Herdman; R Hong; A F Michael; R A Good
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

10.  Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis.

Authors:  C E Alpers; W H Tu; J Hopper; C G Biava
Journal:  Hum Pathol       Date:  1985-03       Impact factor: 3.466

  10 in total
  6 in total

1.  Clinicopathological significance of light chain deposition in IgA nephropathy.

Authors:  Ritsuko Katafuchi; Hiroshi Nagae; Kosuke Masutani; Toshiaki Nakano; Mikio Munakata; Kazuhiko Tsuruya; Koji Mitsuiki
Journal:  Clin Exp Nephrol       Date:  2021-03-01       Impact factor: 2.801

2.  Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy.

Authors:  Hiroshi Nagae; Akihiro Tsuchimoto; Kazuhiko Tsuruya; Shota Kawahara; Yukiko Shimomura; Hideko Noguchi; Kosuke Masutani; Ritsuko Katafuchi; Takanari Kitazono
Journal:  Clin Exp Nephrol       Date:  2016-05-12       Impact factor: 2.801

3.  Light-chain ratio of serum IgA1 in IgA nephropathy.

Authors:  S H Chui; C W Lam; W H Lewis; K N Lai
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

4.  Clinicopathologic and Prognostic Study of Primary IgA Nephropathy With Light Chain λ Restriction in the Mesangial Deposits.

Authors:  Ji Zhang; Ziyuan Huang; Sishi Lin; Ya Hu; Yan Liang; Wenxian Qiu; Bo Chen; Chaosheng Chen
Journal:  Kidney Int Rep       Date:  2022-01-26

5.  Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.

Authors:  Katerina Zachova; Jana Jemelkova; Petr Kosztyu; Yukako Ohyama; Kazuo Takahashi; Josef Zadrazil; Jiri Orsag; Karel Matousovic; Dana Galuszkova; Nadezda Petejova; Jiri Mestecky; Milan Raska
Journal:  J Am Soc Nephrol       Date:  2022-02-03       Impact factor: 14.978

6.  Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity.

Authors:  Yang Shen; Lin Zeng; Aiping Zhu; Tim Blanc; Dipa Patel; Anthony Pennello; Amtul Bari; Stanley Ng; Kris Persaud; Yun Kenneth Kang; Paul Balderes; David Surguladze; Sagit Hindi; Qinwei Zhou; Dale L Ludwig; Marshall Snavely
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.